| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.05 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.17 | 0.05 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |